Routman, during a dedicated poster session. PDS Biotech is committed to innovating immunotherapy approaches for cancer treatment, specifically targeting HPV-associated cancers. PDS Biotech will ...

INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced ...

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

There are over 100 types of human papillomavirus (HPV), and some can lead to different types of cancer, including cancer that affects the nose and throat. These are known as HPV-associated ...

[1] “This reluctance is troubling,” she said,“given the direct link between HPV and cervical cancer. Addressing these fears with credible information is vital to reducing the burden in sub ...

HPV is a leading cause of cervical cancer in women, but 50% of people who develop the cancer are never tested. A self-collection test could help.

[1] “This reluctance is troubling,” she said, “given the direct link between HPV and cervical cancer. Addressing these fears with credible information is vital to reducing the burden in sub-Saharan ...

One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized trial showed. In the ESCUDDO trial, which involved more than 20,000 ...

Information and resources for understanding human papillomavirus. If you have HPV, you might never know it. It’s so common that the CDC estimates that almost 80 million people in the U.S. have it.